WEEKLY RESEARCH · 011 · 2026.11.13
Quantum Orders and Government Capital Improve, but Revenue and Cash Burn Still Limit Returns
Quantum Computing Research Radar | Issue 011 | 13 November 2026
Quantum computing is moving toward contracts, acceptance and manufacturing. Bookings, remaining performance obligations and government funding are different stages, not additive revenue or free cash flow. Paid adoption, margins and cash consumption determine commercial conversion.
Public research | Full access
D-Wave and Rigetti add order, technology and conditional government-funding evidence. Revenue remains small and operating cash flow negative. Higher evidence maturity does not establish investment eligibility.
The one-minute brief
Quantum computing is moving toward contracts, acceptance and manufacturing. Bookings, remaining performance obligations and government funding are different stages, not additive revenue or free cash flow. Paid adoption, margins and cash consumption determine commercial conversion.
Audio transcript
D-Wave and Rigetti add order, technology and conditional government-funding evidence. Revenue remains small and operating cash flow negative. Higher evidence maturity does not establish investment eligibility.
01 · SCORE & MEASUREMENT
Evidence maturity, not expected return
Research evidence maturity is not a price target, return probability or trading signal.
| Module | Prior | Current | Change / Read |
|---|---|---|---|
| Quantum evidence maturity | 58 | 60 | +2; revenue and cash remain constraints |
| D-Wave | 63 | 67 | +4; orders and conditional capital improve |
| Rigetti | UNKNOWN | 64 | Initial comparable observation; no delta |
| IonQ | 82 | 82 | Unchanged; no repeat deep dive |
| Manufacturing and supply chain | 73 | 74 | +1; conditions and execution remain |
02 · WHAT CHANGED
Evidence before narrative
1 | D-Wave orders and cash
Q3 revenue was $4.5m, nine-month bookings $37.4m and RPO $38.3m. Nine-month CFO was -$109.0m and equipment CapEx $13.0m; the original simple FCF proxy was approximately -$122.0m, excluding acquisition cash flows. Cash and securities of $503.4m provide runway, not proof of self-financing operations.
2 | D-Wave counterevidence
Q3 operating loss was $53.5m. Non-GAAP gross margin of 63.6% fell 14.1 percentage points year on year. Large-order concentration, cancellation rights and conversion timing need scrutiny.
3 | Rigetti technology and adoption
Q3 revenue was $1.4m and nine-month revenue $10.9m, with roughly $20m FY26 guidance. Cepheus-1-108Q disclosed 99.5% median two-qubit fidelity. Technical fidelity is not commercial utilization or acceptance. Q4 revenue remains sensitive to C-DAC acceptance.
4 | Rigetti cash burden
Nine-month CFO was -$49.1m and equipment CapEx $42.6m; the original simple FCF proxy was approximately -$91.7m. Cash and investments were $497.1m; Q3 operating loss was $33.2m. Warrant fair-value movements affect accounting net income, requiring separate operating and cash analysis.
5 | Conditional government capital
D-Wave and Rigetti each disclosed access to up to $100m of government support, subject to conditions and milestones. Maximum funding is not cash received, and manufacturing capital is not paying-customer demand.
6 | QUBT remains a lighter monitor
Q3 revenue was $9.5m, backlog about $39.1m, gross margin 4.5%, net loss $15.1m and cash/investments about $1.3bn. LSI, NuCrypt and NHanced acquisitions materially influence revenue, which cannot be treated as organic quantum demand.
7 | Psychology and valuation boundaries
Current FOMO, AI crowding, breadth and quadrant regime are UNKNOWN. Expired 28 October values of 51, 77 and 48 are not reused as current. High commercialization expectations leave returns vulnerable to delays, weak margins and financing dilution.
VALUE-CAPTURE MATRIX
One evidence chain, no double counting
| Stage | Evidence | Open question |
|---|---|---|
| Capability | Qubit, fidelity and platform disclosures | Independent replication, stability and production use |
| Orders | Higher D-Wave bookings and RPO | Cancellation, concentration and timing |
| Revenue | Both companies report revenue | Organic demand, renewal and acceptance |
| Margin and cash | Negative operating cash flow | Margins, spending and dilution |
| Investor return | Substantial cash runway | Independent valuation and margin-of-safety review |
03 · THESIS → EVIDENCE → UPDATE
What the new evidence changes
Prior view
Engineering progress needs revenue and cash proof.
New evidence
Orders, RPO, milestones and conditional public capital improve.
Updated view
Evidence strengthens without bypassing adoption, margin and FCF validation.
04 · NEXT VALIDATION
7D / 30D / 90D
| Window | What to validate |
|---|---|
| 7 days | Funding conditions, milestones, equity rights and accounting. |
| 30 days | D-Wave conversion, Rigetti acceptance, concentration and recognition. |
| 90 days | CFO, equipment spending, margin, stock compensation, dilution and organic revenue. |
FAQ
Questions readers should ask
Can bookings, RPO and revenue be added?
No. They describe different and potentially overlapping stages.
Is maximum funding already cash?
No. Disbursement depends on conditions and milestones.
Does a strong cash balance prove the model?
No. Funding runway and recurring operating cash generation differ.
Is a maturity score of 60 a 60% return probability?
No. It measures research-evidence completeness and commercial maturity.
KEY TERMS
Reader reference
- RPO
- Remaining performance obligations: contracted amounts not yet recognized as revenue, requiring delivery.
- Fidelity
- A technical accuracy measure, not a direct financial-return measure.
- Cash runway
- The period cash can support operations at a given burn rate, distinct from revenue quality.
SOURCES & CONTINUITY
Verifiable sources
D-Wave | Q3 2026 results | 10 Nov 2026 ↗
SEC | D-Wave earnings exhibit | 10 Nov 2026 ↗
Rigetti | Q3 2026 results | 12 Nov 2026 ↗
Continue reading
Research through 17:00 Beijing time on 13 November 2026, covering 6–13 November. Reuses completed research without recalculating valuation or indicators. Private valuation multiples and portfolio actions are excluded. Scores are not return probabilities and funding caps are not cash received. Not investment advice.
